XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses:        
Research and development expense $ 13,538 $ 6,698 $ 25,523 $ 12,331
General and administrative 3,063 3,635 7,117 5,685
Total operating expenses 16,601 10,333 32,640 18,016
Loss from operations (16,601) (10,333) (32,640) (18,016)
Other income, net 797 213 1,513 241
Net loss (15,804) (10,120) (31,127) (17,775)
Accretion to redemption value and cumulative dividends on preferred stock       (1,820)
Net loss attributable to common stockholders $ (15,804) $ (10,120) $ (31,127) $ (19,595)
Net loss per share attributable to common stockholders, basic $ (0.81) $ (0.53) $ (1.60) $ (1.74)
Net loss per share attributable to common stockholders, diluted $ (0.81) $ (0.53) $ (1.60) $ (1.74)
Weighted-average number of shares used in computing net loss per share, basic 19,497,494 19,258,066 19,442,010 11,263,804
Weighted-average number of shares used in computing net loss per share, diluted 19,497,494 19,258,066 19,442,010 11,263,804
Other comprehensive loss:        
Unrealized gain (loss) on investments $ 56 $ (202) $ 255 $ (333)
Comprehensive loss $ (15,748) $ (10,322) $ (30,872) $ (18,108)